000			02264 a2200553 4500
005			20250514061325.0
264		0	_c20030403
008			200304s 0 0 eng d
022			_a0950-9232
024	7		_a10.1038/sj.onc.1206209 _2doi
040			_aNLM _beng _cNLM
100	1		_aTuck, Alan B
245	0	0	_aOsteopontin-induced migration of human mammary epithelial cells involves activation of EGF receptor and multiple signal transduction pathways. _h[electronic resource]
260			_bOncogene _cFeb 2003
300			_a1198-205 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
650	0	4	_aAdenocarcinoma _xpathology
650	0	4	_aBreast _xcytology
650	0	4	_aBreast Neoplasms _xpathology
650	0	4	_aCell Movement _xdrug effects
650	0	4	_aEnzyme Inhibitors _xpharmacology
650	0	4	_aEpidermal Growth Factor _xbiosynthesis
650	0	4	_aEpithelial Cells _xdrug effects
650	0	4	_aErbB Receptors _xbiosynthesis
650	0	4	_aFemale
650	0	4	_aGene Expression Regulation, Neoplastic _xdrug effects
650	0	4	_aHumans
650	0	4	_aMAP Kinase Signaling System _xdrug effects
650	0	4	_aNeoplasm Proteins _xantagonists & inhibitors
650	0	4	_aOligonucleotides, Antisense _xpharmacology
650	0	4	_aOsteopontin
650	0	4	_aPhosphatidylinositol 3-Kinases _xphysiology
650	0	4	_aPhosphoinositide-3 Kinase Inhibitors
650	0	4	_aProtein Kinase C _xantagonists & inhibitors
650	0	4	_aProto-Oncogene Proteins c-met _xdrug effects
650	0	4	_aRNA, Messenger _xbiosynthesis
650	0	4	_aRecombinant Fusion Proteins _xphysiology
650	0	4	_aRecombinant Proteins _xpharmacology
650	0	4	_aSialoglycoproteins _xpharmacology
650	0	4	_aSignal Transduction _xdrug effects
650	0	4	_aTransforming Growth Factor alpha _xantagonists & inhibitors
650	0	4	_aTumor Cells, Cultured _xcytology
650	0	4	_aType C Phospholipases _xantagonists & inhibitors
700	1		_aHota, Charulata
700	1		_aWilson, Sylvia M
700	1		_aChambers, Ann F
773	0		_tOncogene _gvol. 22 _gno. 8 _gp. 1198-205
856	4	0	_uhttps://doi.org/10.1038/sj.onc.1206209 _zAvailable from publisher's website
999			_c12403129 _d12403129